Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human-Derived Mesenchymal Stem Cell Conditioned Medium for Xerotic Skin Disorders
jRCT1051260125Recruiting
- Sponsor
- Heiwa Clinic
- Start
- Apr 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in Asteatosis, sponsored by Heiwa Clinic. Primary endpoint: Change in patient condition by questionnaire at 1 month. Started Apr 2024; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
Asteatosis
Beyond the preview
Go deeper on jRCT1051260125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260125.